Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Octomera
Germantown, Maryland, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Octomera operates a decentralized network of harmonized point-of-care centers (“POCare Centers”) that provide standardized, scalable manufacturing services for cell and gene therapies. The company’s proprietary OMPULs enable rapid deployment of GMP-compliant production processes across multiple sites. Octomera’s model aims to reduce the cost, complexity, and time required to develop and commercialize advanced therapies by shifting from centralized to decentralized manufacturing. The company also supports internal R&D programs in oncology with demonstrated proof-of-concept data.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyGene therapy
- Industry
- Contract Manufacturing Organization
02
Partnerships
Academic instituteshospitalsindustry partners via the POCare NetworkPrivate equity investment from Metalmark Capital Partners/MM OS Holdings L.P.
Beyond the preview
Go deeper on Octomera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Octomera.